{"slideshow_credits": null, "snippet": "It\u2019s supposed to control medical costs. But in reality, it\u2019s a nightmare.", "abstract": "Op-Ed article by Dr Danielle Ofri describes bureaucratic nightmare that ensues for doctors and their medical practices when insurance companies demand prior authorizations for medications; contends while practice can save money for insurance companies, it does so only initially, since patients denied their medications often have higher medical costs in the long run.", "section_name": "Opinion", "print_page": "21", "document_type": "article", "byline": {"person": [{"firstname": "Danielle", "role": "reported", "lastname": "OFRI", "rank": 1, "organization": ""}], "original": "By DANIELLE OFRI", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/08/04/opinion/adventures-in-prior-authorization.html", "lead_paragraph": "It\u2019s supposed to control medical costs. But in reality, it\u2019s a nightmare.", "headline": {"main": "Adventures in \u2018Prior Authorization\u2019", "print_headline": "Adventures in \u2018Prior Authorization\u2019", "content_kicker": "Op-Ed Contributor", "kicker": "Op-Ed Contributor"}, "_id": "53decfa838f0d828c6bf0a9b", "word_count": "842", "multimedia": [{"height": 126, "url": "images/2014/08/04/opinion/0804OPEDmenchin/0804OPEDmenchin-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/08/04/opinion/0804OPEDmenchin/0804OPEDmenchin-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 754, "url": "images/2014/08/04/opinion/0804OPEDmenchin/0804OPEDmenchin-articleLarge.jpg", "legacy": {"xlarge": "images/2014/08/04/opinion/0804OPEDmenchin/0804OPEDmenchin-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "754"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/08/04/opinion/0804OPEDmenchin/0804OPEDmenchin-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/08/04/opinion/0804OPEDmenchin/0804OPEDmenchin-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-08-04T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Health Insurance and Managed Care", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Doctors", "name": "subject", "is_major": "Y", "rank": "2"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}